{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:32:35Z","timestamp":1760297555502},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00108-005-1492-8","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T08:43:09Z","timestamp":1129711389000},"page":"1373-1388","source":"Crossref","is-referenced-by-count":3,"title":["Kardiomyopathien","Cardiomyopathies"],"prefix":"10.1007","volume":"46","author":[{"given":"H.-P.","family":"Schultheiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Noutsias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"K\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lassner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Poller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pauschinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1492_CR1","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1161\/01.CIR.101.21.2490","volume":"101","author":"Ammash","year":"2000","unstructured":"Ammash NM, Seward JB, Bailey KR, Edwards WD, Tajik AJ (2000) Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation 101: 2490\u20132496","journal-title":"Circulation"},{"key":"1492_CR2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0008-6363(01)00261-9","volume":"50","author":"Basso","year":"2001","unstructured":"Basso C, Calabrese F, Corrado D, Thiene G (2001) Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res 50: 290\u2013300","journal-title":"Cardiovasc Res"},{"key":"1492_CR3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.CIR.94.5.983","volume":"94","author":"Basso","year":"1996","unstructured":"Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M (1996) Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 94: 983\u2013991","journal-title":"Circulation"},{"key":"1492_CR4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/01.CIR.0000117089.99918.5A","volume":"109","author":"Chang","year":"2004","unstructured":"Chang SM, Lakkis NM, Franklin J, Spencer WH 3rd, Nagueh SF (2004) Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation 109: 824\u2013827","journal-title":"Circulation"},{"key":"1492_CR5","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/01.CIR.97.22.2230","volume":"97","author":"Charron","year":"1998","unstructured":"Charron P, Dubourg O, Desnos M et al. (1998) Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin\u2013binding protein C gene. Circulation 97: 2230\u20132236","journal-title":"Circulation"},{"key":"1492_CR6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI200317612","volume":"111","author":"Chien","year":"2003","unstructured":"Chien KR (2003) Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies. J Clin Invest 111: 175\u2013178","journal-title":"J Clin Invest"},{"key":"1492_CR7","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","volume":"108","author":"Corrado","year":"2003","unstructured":"Corrado D, Leoni L, Link MS et al. (2003) Implantable cardioverter\u2013defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia. Circulation 108: 3084\u20133091","journal-title":"Circulation"},{"key":"1492_CR8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00392-003-0878-7","volume":"92","author":"Faber","year":"2003","unstructured":"Faber L, Seggewiss H, Welge D et al. (2003) Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy. Z Kardiol 92: 39\u201347","journal-title":"Z Kardiol"},{"key":"1492_CR9","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(01)06657-0","volume":"358","author":"Franz","year":"2001","unstructured":"Franz WM, Muller OJ, Katus HA (2001) Cardiomyopathies: from genetics to the prospect of treatment. Lancet 358: 1627\u20131637","journal-title":"Lancet"},{"key":"1492_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","volume":"345","author":"Frustaci","year":"2001","unstructured":"Frustaci A, Chimenti C, Ricci R et al. (2001) Improvement in cardiac function in the cardiac variant of Fabry\u2019s disease with galactose-infusion therapy. N Engl J Med 345: 25\u201332","journal-title":"N Engl J Med"},{"key":"1492_CR11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.CIR.0000022845.80802.9D","volume":"106","author":"Gietzen","year":"2002","unstructured":"Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H (2002) Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions. Circulation 106: 454\u2013459","journal-title":"Circulation"},{"key":"1492_CR12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1196\/annals.1302.018","volume":"1015","author":"Gomes","year":"2004","unstructured":"Gomes AV, Potter JD (2004) Molecular and cellular aspects of troponin cardiomyopathies. Ann N Y Acad Sci 1015: 214\u2013224","journal-title":"Ann N Y Acad Sci"},{"key":"1492_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000006794","volume":"89","author":"Grumbach","year":"1998","unstructured":"Grumbach IM, Heim A, Vonhof S et al. (1998) Coxsackievirus genome in myocardium of patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Cardiology 89: 241\u2013245","journal-title":"Cardiology"},{"key":"1492_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/heart.86.3.343","volume":"86","author":"Hancock","year":"2001","unstructured":"Hancock EW (2001) Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis. Heart 86: 343\u2013349","journal-title":"Heart"},{"key":"1492_CR15","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/0735-1097(91)90540-P","volume":"18","author":"Katritsis","year":"1991","unstructured":"Katritsis D, Wilmshurst PT, Wendon JA, Davies MJ, Webb-Peploe MM (1991) Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 18: 1230\u20131235","journal-title":"J Am Coll Cardiol"},{"key":"1492_CR16","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0002-9149(84)91473-5","volume":"53","author":"Kim","year":"1984","unstructured":"Kim CH, Vlietstra RE, Edwards WD, Reeder GS, Gleich GJ (1984) Steroid-responsive eosinophilic myocarditis: diagnosis by endomyocardial biopsy. Am J Cardiol 53: 1472\u20131473","journal-title":"Am J Cardiol"},{"key":"1492_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1388-9842(99)00026-4","volume":"1","author":"Komajda","year":"1999","unstructured":"Komajda M, Charron P, Tesson F (1999) Genetic aspects of heart failure. Eur J Heart Fail 1: 121\u2013126","journal-title":"Eur J Heart Fail"},{"key":"1492_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1056\/NEJM199701233360407","volume":"336","author":"Kushwaha","year":"1997","unstructured":"Kushwaha SS, Fallon JT, Fuster V (1997) Restrictive cardiomyopathy. N Engl J Med 336: 267\u2013276","journal-title":"N Engl J Med"},{"key":"1492_CR19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1054-8807(03)00036-X","volume":"12","author":"Lamke","year":"2003","unstructured":"Lamke GT, Allen RD, Edwards WD, Tazelaar HD, Danielson GK (2003) Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy. A study of 204 cases (1996\u20132000). Cardiovasc Pathol 12: 149\u2013158","journal-title":"Cardiovasc Pathol"},{"key":"1492_CR20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0002-9149(98)01065-0","volume":"83","author":"Linde","year":"1999","unstructured":"Linde C, Gadler F, Kappenberger L, Ryden L (1999) Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. Am J Cardiol 83: 903\u2013907","journal-title":"Am J Cardiol"},{"key":"1492_CR21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)82005-X","volume":"355","author":"Maron","year":"2000","unstructured":"Maron BJ (2000) Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy. Lancet 355: 425\u2013426","journal-title":"Lancet"},{"key":"1492_CR22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jama.281.7.650","volume":"281","author":"Maron","year":"1999","unstructured":"Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM (1999) Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 281: 650\u2013655","journal-title":"JAMA"},{"key":"1492_CR23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"Maron","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92: 785\u2013789","journal-title":"Circulation"},{"key":"1492_CR24","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","unstructured":"Maron BJ, McKenna WJ, Danielson GK et al. (2003) American College of Cardiology\/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42: 1687\u20131713","journal-title":"J Am Coll Cardiol"},{"key":"1492_CR25","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1161\/01.CIR.99.22.2927","volume":"99","author":"Maron","year":"1999","unstructured":"Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS (1999) Assessment of permanent dual\u2013chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M\u2013PATHY). Circulation 99: 2927\u20132933","journal-title":"Circulation"},{"key":"1492_CR26","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.CIR.102.8.858","volume":"102","author":"Maron","year":"2000","unstructured":"Maron BJ, Olivotto I, Spirito P et al. (2000) Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 102: 858\u2013864","journal-title":"Circulation"},{"key":"1492_CR27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0002-9149(81)90535-X","volume":"47","author":"McKenna","year":"1981","unstructured":"McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J (1981) Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 47: 532\u2013538","journal-title":"Am J Cardiol"},{"key":"1492_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/hrt.71.3.215","volume":"71","author":"McKenna","year":"1994","unstructured":"McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F (1994) Diagnosis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71: 215\u2013218","journal-title":"Br Heart J"},{"key":"1492_CR29","first-page":"II274","volume":"72","author":"Metras","year":"1985","unstructured":"Metras D, Coulibaly AO, Ouattara K (1985) The surgical treatment of endomyocardial fibrosis: results in 55 patients. Circulation 72: II274\u2013279","journal-title":"Circulation"},{"key":"1492_CR30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.CIR.52.1.88","volume":"52","author":"Morrow","year":"1975","unstructured":"Morrow AG, Reitz BA, Epstein SE, Henry WL, Conkle DM, Itscoitz SB, Redwood DR (1975) Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation 52: 88\u2013102","journal-title":"Circulation"},{"key":"1492_CR31","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.0000142293.60725.18","volume":"110","author":"Nasir","year":"2004","unstructured":"Nasir K, Bomma C, Tandri H et al. (2004) Electrocardiographic features of arrhythmogenic right ventricular dysplasia\/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 110: 1527\u20131534","journal-title":"Circulation"},{"key":"1492_CR32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-129-11_Part_2-199812011-00003","volume":"129","author":"Barton","year":"1998","unstructured":"Barton JC, McDonnell SM, Adams PC et al. (1998) Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 129: 932\u2013939","journal-title":"Ann Intern Med"},{"key":"1492_CR33","first-page":"367","volume":"11","author":"Oni","year":"1992","unstructured":"Oni AA, Hershberger RE, Norman DJ, Ray J, Hovaguimian H, Cobanoglu AM, Hosenpud JD (1992) Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 11: 367\u2013369","journal-title":"J Heart Lung Transplant"},{"key":"1492_CR34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1586\/14779072.2.1.53","volume":"2","author":"Prasad","year":"2004","unstructured":"Prasad SK, Kotwinski P, Assomul R (2004) The role of cardiovascular magnetic resonance in the evaluation of patients with heart failure. Expert Rev Cardiovasc Ther 2: 53\u201359","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1492_CR35","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","volume":"107","author":"Richard","year":"2003","unstructured":"Richard P, Charron P, Carrier L et al. (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107: 2227\u20132232","journal-title":"Circulation"},{"key":"1492_CR36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0002-9343(69)90055-2","volume":"46","author":"Roberts","year":"1969","unstructured":"Roberts WC, Liegler DG, Carbone PP (1969) Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med 46: 28\u201342","journal-title":"Am J Med"},{"key":"1492_CR37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0140-6736(95)91267-3","volume":"346","author":"Sigwart","year":"1995","unstructured":"Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346: 211\u2013214","journal-title":"Lancet"},{"key":"1492_CR38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","volume":"100","author":"Skinner","year":"1996","unstructured":"Skinner M, Anderson J, Simms R et al. (1996) Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 100: 290\u2013298","journal-title":"Am J Med"},{"key":"1492_CR39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0092-8674(90)90273-H","volume":"62","author":"Tanigawa","year":"1990","unstructured":"Tanigawa G, Jarcho JA, Kass S, Solomon SD, Vosberg HP, Seidman JG, Seidman CE (1990) A molecular basis for familial hypertrophic cardiomyopathy: an alpha\/beta cardiac myosin heavy chain hybrid gene. Cell 62: 991\u2013998","journal-title":"Cell"},{"key":"1492_CR40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s000590050008","volume":"25","author":"Thiene","year":"2000","unstructured":"Thiene G, Basso C, Calabrese F, Angelini A, Valente M (2000) Pathology and pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Herz 25: 210\u2013215","journal-title":"Herz"},{"key":"1492_CR41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s000590050028","volume":"25","author":"van der Wall","year":"2000","unstructured":"van der Wall EE, Kayser HW, Bootsma MM, de Roos A, Schalij MJ (2000) Arrhythmogenic right ventricular dysplasia: MRI findings. Herz 25: 356\u2013364","journal-title":"Herz"},{"key":"1492_CR42","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.CIR.86.1.29","volume":"86","author":"Wichter","year":"1992","unstructured":"Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G (1992) Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 86: 29\u201337","journal-title":"Circulation"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-005-1492-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-005-1492-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-005-1492-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:18:52Z","timestamp":1683260332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-005-1492-8"}},"subtitle":["Teil II: Hypertrophe Kardiomyopathie, restriktive Kardiomyopathie, arrhythmogene rechtsventrikul\u00e4re Kardiomyopathie"],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["1492"],"URL":"https:\/\/doi.org\/10.1007\/s00108-005-1492-8","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}